(Q58244215)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Therapy of bovine ocular squamous-cell carcinoma with local doses of interleukin-2: 67% complete regressions after 20 months of follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

0 references

11

Victor P. M. G. Rutten

0 references

E. Joost Ruitenberg

10

object named as

E J Ruitenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

W Den Otter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

F W Hill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

W R Klein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J W Koten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

P A Steerenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

P H De Mulder

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

C Rhode

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

R Stewart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J A Faber

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

22 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

10-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01788954

22 October 2019

exact match

0 references

cites work

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

12 December 2020

Local interleukin-2 therapy in bovine ocular squamous cell carcinoma

1 reference

12 December 2020

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

12 December 2020

Tumour regression by IL-2 mediated stagnation of blood flow

1 reference

12 December 2020

Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary report

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinoma

1 reference

12 December 2020

Effective immunotherapy with local low doses of interleukin-2.

1 reference

12 December 2020

Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumors

1 reference

12 December 2020

Low doses of interleukin-2 can cure large bovine ocular squamous cell carcinoma

1 reference

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.

1 reference

12 December 2020

Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour

1 reference

12 December 2020

Oncogenesis by mutations in anti-oncogenes: a view

1 reference

12 December 2020

Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2.

1 reference

12 December 2020

The difference between benign and malignant tumours explained with the 4-mutation paradigm for carcinogenesis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01788954

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641215%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference